Evaluation of the Influence of Clinical, Demographic, and Laboratory Factors on Treatment Modality Selection in Patients with Acute Myocardial Infarction
Abstract
Abstract Introduction Acute myocardial infarction (AMI) remains one of the leading causes of mortality and disability worldwide. The management of patients with AMI requires prompt, evidence-based clinical decision-making. Variations in patients' demographic, clinical, and laboratory characteristics may directly influence the choice of treatment strategy and the prognosis of AMI, thereby reducing complications and promoting faster recovery with minimal cardiac damage. However, substantial uncertainty remains regarding the extent to which these variables are associated with the selection of therapeutic protocols, warranting further investigation. Objective This study aimed to evaluate the demographic, clinical, and laboratory characteristics of patients with acute myocardial infarction and to investigate their association with the selected treatment modality. Methods This cross-sectional study was conducted in 2023 among patients with acute myocardial infarction admitted to the Coronary Care Unit (CCU) of Ayatollah Mousavi Hospital in Zanjan, Iran. Data were collected using a three-part checklist consisting of demographic information, clinical characteristics, and laboratory findings. The collected data were entered into SPSS software version 24 and analyzed using appropriate statistical methods. Results A total of 293 patients were included in the study (mean age: 59.35 ± 12.18 years; 77.1% male). The most common age group was 51–65 years (43%), and anterior ST-segment…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 293 participants or records.
Read the paper
Related studies
- Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: A randomized controlled trial
- A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
- Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
- Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial
- A Multi-Ingredient Nutritional Supplement in Combination With Resistance Exercise and High-Intensity Interval Training Improves Cognitive Function and Increases N-3 Index in Healthy Older Men: A Randomized Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.